Clinical Trial Update: Genetic Testing of CYP2C19 in Prognostic Evaluation of Long-Term Major Adverse Cardiac and Vascular Events

View source ↗

Summary

A clinical trial update evaluating whether CYP2C19 genetic testing can prognosticate long-term risk of major adverse cardiac and vascular events in patients wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis of the Coronary Arteries
• Atherosclerotic Vascular Disease
• Coronary Artery Disease
• Peripheral Artery Disease
• Stroke
• Venous Thromboembolism

Snippet

Sponsor: University of Florida | Conditions: Atherosclerotic Vascular Disease, Coronary Arterial Disease (CAD) | Status: ACTIVE_NOT_RECRUITING